Verve’s Proof-Of-Concept Data Doesn’t Inspire Confidence (NASDAQ:VERV)


Carol Yepes/Moment via Getty Images

Verve's Genetic Game: Rewriting the Cholesterol Script

Therapeutic Verve (NASDAQ:VERV) aims to change the way we treat cardiovascular disease.

With a myriad of safe, affordable, reliable and effective medications like statins, SGLT-2 inhibitors, PCSK9



Source link

Scroll to Top